The abstract is read at the publisher; the summary is JClub's.
Electronically tunable N-terminal glycine bioconjugation enables species-specific targeting and in vivo labeling of Staphylococcus aureus, including resistant strains, in Drosophila and mice.
- Why it matters: Precise biomolecule targeting in living systems is difficult because selectivity must hold amid complex biological components and diverse bacterial states.
- What they did: The authors developed an electronically tunable chemistry that reacts with N-terminal glycine, validated with peptides and proteins, and tested reactivity, selectivity, and bioconjugate stability under bioadditives.
- The result: The approach supports species-specific detection, late-stage installation of multiple biorthogonal handles, and in vivo labeling in Drosophila and mouse skin, tissue, and blood infections, with N-terminal glycine modification inhibiting drug-susceptible and drug-resistant clinical strains, including biofilm formation, in mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.